BridgeMD
Compares treatment options for Variation of Keratinized Mucosa After Implant Surgery
Official title Keratized Mucosa in CG Implant Placement: CTG vs Flapless
ClinicalTrials.gov ID: NCT05073952
What this study is testing
- What it's testing
- The present study will evaluate the difference in terms of keratinazed mucosa (KM) in computer guided implant placement with immediate loading, comparing a flapless approach to flap surgery with connective tissue graft.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- Age 18+
- Patients with partial edentulism in the posterior region (4-7) upper or lower for at least 3 months
- Patient whose tomographic examination shows adequate bone volumes for computer guided placement of a standard diameter implant (\> 3.5 mm) without...
- Patients who have accepted informed consent and participation in the study
- Patients who do not have
You likely can't join if
- Eclusion Criteria
- Patients who refuse to co-operate
- Systemic conditions of exclusion:
- Medical conditions requiring prolonged use of steroids
- Severe hemophilia
- In therapy with intravenous bisphosphonates
See the full eligibility criteria
- Age 18+
- Patients with partial edentulism in the posterior region (4-7) upper or lower for at least 3 months
- Patient whose tomographic examination shows adequate bone volumes for computer guided placement of a standard diameter implant (\> 3.5 mm) without the need for bone regeneration procedures
- Patients who have accepted informed consent and participation in the study
- Patients who do not have
- Eclusion Criteria
- Patients who refuse to co-operate
- Systemic conditions of exclusion:
- Medical conditions requiring prolonged use of steroids
- Severe hemophilia
- In therapy with intravenous bisphosphonates
- History of white blood cell dysfunction or deficiency
- History of head and neck radiotherapy or chemotherapy
- History of kidney failure
- Pregnant or breastfeeding patient
- History of uncontrolled endocrine disorders
- Physical handicaps that hinder proper oral hygiene
- Use of experimental devices or drugs within 30 days prior to implant placement surgery
- Alcoholism or drug abuse
- Smokers of\> 10 cigarettes per day or the equivalent cigar or\> 10 tobacco-based chewings per day
- Conditions or circumstances that prevent the completion of participation in the study or interfere with the analysis of the study results Local exclusion conditions:
- Local inflammation, including untreated periodontitis
- Patients with erosive lichen planus
- History of local radiation therapy
- Presence of bone lesions
- Unhealed extraction sites
- History of bone reconstruction and bone grafting techniques in the sites where the implants are to be inserted
- Bruxism
- Bleeding index\> 30% and number of pockets\> 5mm greater than 10
The study team makes the final eligibility decision.
Where it's taking place
- Milan, MI, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Milan, MI, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.